Statistical flag only — not an accusation of fraud
⚠️ This provider averages 870 services per working day — physically unusual for an individual practitioner
Based on 2.2M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $27.4M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 870 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 113% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 68/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 71% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $38.31 | $13.84 | 2.77x | $24.47 | $2.0M | 142.6K | 42 |
| 2015 | $47.37 | $17.19 | 2.76x | $30.18 | $1.9M | 112.3K | 48 |
| 2016 | $27.30 | $10.43 | 2.62x | $16.87 | $1.9M | 177.8K | 47 |
| 2017 | $25.37 | $9.27 | 2.74x | $16.10 | $1.9M | 208.1K | 51 |
| 2018 | $32.90 | $13.59 | 2.42x | $19.31 | $3.0M | 218.7K | 57 |
| 2019 | $31.79 | $12.73 | 2.50x | $19.06 | $3.1M | 242.3K | 57 |
| 2020 | $36.83 | $13.85 | 2.66x | $22.98 | $4.2M | 303.3K | 52 |
| 2021 | $30.84 | $11.52 | 2.68x | $19.32 | $2.8M | 238.8K | 48 |
| 2022 | $34.32 | $13.25 | 2.59x | $21.07 | $2.5M | 185.4K | 49 |
| 2023 | $43.26 | $12.16 | 3.56x | $31.10 | $4.2M | 344.9K | 58 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 106.8K | $4.3M | $40.30 | 2.26x |
| J9299 | Injection, nivolumab, 1 mg | 164.4K | $3.7M | $22.23 | 2.21x |
| J2505 | Injection, pegfilgrastim, 6 mg | 733 | $2.3M | $3.1K | 2.01x |
| J0897 | Injection, denosumab, 1 mg | 102.1K | $1.5M | $14.72 | 2.14x |
| J9035 | Injection, bevacizumab, 10 mg | 20.9K | $1.2M | $56.05 | 2.21x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 136.1K | $1.2M | $8.58 | 2.29x |
| J9310 | Injection, rituximab, 100 mg | 1.9K | $1.1M | $592.96 | 2.22x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 118.3K | $1.0M | $8.70 | 3.68x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 7.5K | $726.4K | $97.35 | 2.96x |
| J9022 | Injection, atezolizumab, 10 mg | 10.5K | $656.3K | $62.72 | 2.44x |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 11.6K | $540.6K | $46.77 | 3.44x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 10.1K | $530.0K | $52.32 | 1.86x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 11.1K | $449.3K | $40.40 | 3.36x |
| J9311 | Injection, rituximab 10 mg and hyaluronidase | 12.9K | $438.1K | $34.01 | 3.95x |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 2.7K | $434.0K | $162.90 | 4.14x |
| J9041 | Injection, bortezomib, 0.1 mg | 16.4K | $397.6K | $24.27 | 3.73x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 4.7K | $389.6K | $82.11 | 1.78x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 390 | $381.5K | $978.20 | 2.80x |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 5.0K | $359.8K | $71.77 | 2.59x |
| J9312 | Injection, rituximab, 10 mg | 4.8K | $358.3K | $74.48 | 1.79x |
This provider submits charges 2.77 times higher than what Medicare actually pays.
A markup ratio of 2.77x means for every $100 Medicare pays, this provider initially charges $277. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in KS for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Pavan Reddy, M.D. | Wichita, KS | $52.9M | ⚠️ Flagged |
| Bassam Mattar, MD | Wichita, KS | $50.2M | ⚠️ Flagged |
| Dennis Moore, MD | Wichita, KS | $44.1M | ⚠️ Flagged |
| Shaker Dakhil, MD | Wichita, KS | $41.0M | ⚠️ Flagged |
| Jeremy Deutsch, MD | Wichita, KS | $39.7M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data